Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Biogen Inc. (BIIB)

336.71   0.07 (0.02%) 02-21 16:00
Open: 336.97 Pre. Close: 336.64
High: 337.82 Low: 334.6
Volume: 923,304 Market Cap: 58609M
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 338.067 - 339.669 339.669 - 341.175
Low: 330.418 - 332.298 332.298 - 334.065
Close: 333.67 - 336.58 336.58 - 339.313

Technical analysis

as of: 2020-02-21 4:28:09 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 437.99     One year: 511.57
Support: Support1: 308.62    Support2: 267.59
Resistance: Resistance1: 374.99    Resistance2: 437.99
Pivot: 323.69
Moving Average: MA(5): 336.90     MA(20): 312.83
MA(100): 286.14     MA(250): 259.62
MACD: MACD(12,26): 12.85     Signal(9): 10.79
Stochastic oscillator: %K(14,3): 65.68     %D(3): 65.38
RSI: RSI(14): 67.70
52-week: High: 374.99  Low: 215.78  Change(%): 2.8
Average Vol(K): 3-Month: 178718  10-Days: 150842

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
BIIB has closed below upper band by 36.8%. Bollinger Bands are 130.5% wider than normal. The large width of the bands suggest high volatility as compared to BIIB's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

Fri, 21 Feb 2020 13:01:00 +0000
Top Stocks Warren Buffett Just Bought

Tue, 18 Feb 2020 08:32:59 +0000
16 Stocks Warren Buffett Is Buying and Selling

Wed, 19 Feb 2020 12:32:00 +0000
Warren Buffett's Big Biotech Bet Is 1 of His Riskiest Wagers Ever

Tue, 18 Feb 2020 16:47:22 +0000
IBB, GILD, VRTX, BIIB: ETF Outflow Alert

Tue, 18 Feb 2020 07:22:37 +0000
Stock Alert: Warren Buffett's Berkshire Hathaway Reveals Stake In Kroger, Biogen

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 174.06
Shares Float (M) 173.73
% Held by Insiders 0.62
% Held by Institutions 93.69
Shares Short (K) 4330
Shares Short P. Month (K)

Stock Financials

EPS 31.420
Book Value (p.s.) 76.600
PEG Ratio 2.73
Profit Margin 40.96
Operating Margin 50.60
Return on Assets (ttm) 17.3
Return on Equity (ttm) 44.7
Qtrly Rev. Growth 4.1
Gross Profit (p.s.) 71.355
Sales Per Share
EBITDA (p.s.) 44.467
Qtrly Earnings Growth 52.10
Operating Cash Flow (M) 7080.00
Levered Free Cash Flow (M) 4640.00

Stock Valuations

P/E 10.72
P/E Growth Ratio
P/BV 4.40
P/S 4.38
P/CF 8.28

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio 3
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.